Availability of Insulin Products Will Help Increase Access and Potentially Lower the Cost of Insulin for People with Diabetes Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes…

Continue Reading